Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 25, 2015 3:45 AM ET

Biotechnology

Company Overview of ISA Pharmaceuticals B.V.

Executive Profile

Gerard Platenburg

Chief Innovation Officer, ProQR Therapeutics N.V.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
50$12,000

Background

Mr. Gerard Platenburg has been the Chief Innovation Officer of ProQR Therapeutics NV since February 2014. Mr. Platenburg is a Founder of Prosensa Holding N.V. (Prosensa B.V.) and serves as its Chief Development Officer. Mr. Platenburg served as Chief Executive Officer of ISA Pharmaceuticals B.V. Mr. Platenburg joined Prosensa in 2002 as one of the founders, and responsible for general management, including investor relations. He has more than 20 years senior managerial ...

Corporate Headquarters

Niels Bohrweg 11-13
Leiden, Zuid-Holland 2333 CA

Netherlands

Phone: 31 71 332 2310
Fax: 31 71 332 2311

Board Members Memberships

There is no Board Members Memberships data available.

Education

Unknown/Other Education
Universiteit Leiden

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Calculated Compensation$12,000
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ISA Pharmaceuticals B.V., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.